Finance

Beta
Lists
TE1:FRA
BIO-TECHNE Corp
€42.30
-0.42%
(-0.18) 1D
Jun 3, 8:05:16 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TE1...
Open
€42.30
High
€42.30
Low
€42.30
Mkt. cap
7.77B
Avg. vol.
3.00
Volume
0.00
52-wk high
€60.50
52-wk low
€36.26
No. of employees
3K
Open
€42.30
High
€42.30
Low
€42.30
Mkt. cap
7.77B
Avg. vol.
3.00
Volume
0.00
52-wk high
€60.50
52-wk low
€36.26
No. of employees
3K
News stories
From sources across the web
Profile
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
About BIO-TECHNE Corp
CEOCharles R. Kummeth
Employees3.1K
Founded1976
HeadquartersMinneapolis, Minnesota, United States
SectorHealth care
Websitebio-techne.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
316.96M
286.56M
295.88M
311.42M
Cost of goods sold
105.81M
96.36M
102.69M
101.98M
Cost of revenue
105.81M
96.36M
102.69M
101.98M
Research and development expenses
29.46M
24.24M
23.12M
23.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
66.64M
117.57M
111.87M
107.54M
Operating expense
96.10M
141.81M
134.99M
130.99M
Total operating expenses
201.92M
238.18M
237.68M
232.97M
Operating income
115.05M
48.38M
58.20M
78.45M
Other non operating income
680.00K
2.00M
-2.51M
-2.11M
EBT including unusual items
-22.86M
47.99M
50.78M
71.22M
EBT excluding unusual items
116.69M
48.71M
54.52M
74.18M
Income tax expense
-5.18M
9.81M
12.78M
20.18M
Effective tax rate
22.66%
20.43%
25.16%
28.33%
Other operating expenses
-
-
-
-
Net income
-17.68M
38.18M
38.01M
51.05M
Net profit margin
-5.58%
13.33%
12.85%
16.39%
Earnings per share
0.53
0.42
0.46
0.53
Interest and investment income
585.00K
971.00K
897.00K
981.00K
Interest expense
-2.18M
-2.93M
-2.17M
-2.40M
Net interest expenses
-1.59M
-1.96M
-1.27M
-1.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
142.16M
72.72M
82.91M
102.62M
Gain or loss from assets sale
84.16M
-6.79M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer